Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SF3B3 | Q15393 | 8/20 | 0.44 |
| ▸ | HMGCR | P04035 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | GMNN | O75496 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18672301 | 0.90 | SF3B3 (0.49) | SF3B3 | |
| SCHEMBL13503202 | 0.86 | SF3B3 (0.51) | SF3B3HMGCRMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL15296992 | 0.86 | SF3B3 (0.50) | SF3B3HMGCR | |
| SCHEMBL15296993 | 0.86 | SF3B3 (0.50) | SF3B3HMGCR | |
| SCHEMBL16705979 | 0.86 | SF3B3 (0.50) | SF3B3HMGCR | |
| SCHEMBL16705960 | 0.86 | SF3B3 (0.50) | SF3B3HMGCR | |
| SCHEMBL18672297 | 0.85 | SF3B3 (0.38) | SF3B3 | |
| SCHEMBL22062173 | 0.85 | SF3B3 (0.43) | SF3B3HMGCRMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL22062185 | 0.85 | SF3B3 (0.43) | SF3B3HMGCRMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL14396197 | 0.84 | SF3B3 (0.55) | SF3B3HMGCRMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230029301-A1 | SCALEABLE PREPARATION OF POLYKETIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230029301-A1 | SCALEABLE PREPARATION OF POLYKETIDES | COASY, DHPS, PBK | SF3B3 3277/4885HMGCR 89/4885MEN1 2215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.